Company Valuation: Verastem, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 373.5 84.56 205.7 230.1 595.8 650.2 - -
Change - -77.36% 143.23% 11.87% 158.95% 9.13% - -
Enterprise Value (EV) 1 373.5 84.56 205.7 230.1 595.8 692.1 650.2 650.2
Change - -77.36% 143.23% 11.87% 158.95% 16.16% -6.05% 0%
P/E -5x -1.06x -2.06x -1.41x -2.56x -4.48x -6.16x -8.96x
PBR - - - - - - - -
PEG - 0.14x 0.2x 0.19x 0.1x 0.1x 0.2x 0.3x
Capitalization / Revenue 182x 32.6x - 23x 19.3x 5.58x 3.59x 2.5x
EV / Revenue 182x 32.6x - 23x 19.3x 5.94x 3.59x 2.5x
EV / EBITDA - - - - - - - -
EV / EBIT -6.08x -1.16x -2.23x -2x -3.5x -3.99x -4.17x -5.64x
EV / FCF - - -2.38x -2.2x -4.05x -4.17x -4.34x -6.63x
FCF Yield - - -42% -45.5% -24.7% -24% -23% -15.1%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -4.92 -4.56 -3.96 -3.66 -3.02 -1.603 -1.165 -0.8017
Distribution rate - - - - - - - -
Net sales 1 2.053 2.596 - 10 30.91 116.4 181.1 259.9
EBITDA - - - -114.9 - - - -
EBIT 1 -61.41 -72.94 -92.08 -115 -170.1 -173.4 -155.9 -115.4
Net income 1 -71.2 -73.81 -87.37 -130.6 -209.5 -165.9 -157.1 -114.4
Net Debt 1 - - - - - 41.9 - -
Reference price 2 24.600 4.830 8.140 5.170 7.720 7.180 7.180 7.180
Nbr of stocks (in thousands) 15,182 17,508 25,268 44,507 77,182 90,563 - -
Announcement Date 28/03/22 14/03/23 14/03/24 20/03/25 04/03/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-4.48x5.94x - - 650M
21.98x7.69x15.68x1.34% 73.25B
35.55x9.09x27.97x0.04% 61.95B
-81.11x15.16x-77.38x-.--% 28.02B
30.63x6x15.89x-.--% 24.15B
-14.36x4.96x-6.48x-.--% 23.01B
53.29x19.73x39.94x0.07% 18.35B
26.57x5.01x16.8x-.--% 19.46B
-664.91x38.2x-17593.58x-.--% 15.92B
16.23x4.79x11.18x-.--% 12.96B
Average -58.06x 11.66x -1,950.00x 0.16% 27.77B
Weighted average by Cap. -24.97x 10.60x -1,003.04x 0.37%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. VSTM Stock
  4. Valuation Verastem, Inc.